Metoprolol Tartrate Milpharm (Metoprolol Tartrate)

The drug selectively blocks β1‑adrenergic receptors located primarily in the heart. By inhibiting the action of adrenaline and noradrenaline on these receptors, it reduces heart rate, myocardial contractility, and conduction velocity, leading to decreased cardiac output and lower blood pressure while preserving β2‑receptor activity in the lungs and vasculature.

The appropriate dose of Metoprolol Tartrate Milpharm is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerability. Dosage adjustments are made according to blood pressure readings, heart rate, and clinical judgment, and should never be altered without professional guidance.

Safety data for Metoprolol Tartrate in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate each case individually and discuss alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Metoprolol Tartrate is a cardio‑selective β1‑blocker, offering a favorable profile for patients with hypertension or angina who also have respiratory concerns, as it spares β2 receptors. Compared with non‑selective agents like propranolol, it tends to cause fewer bronchospastic events while providing comparable heart‑rate control.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains tightly closed to maintain product stability throughout its shelf life.

Metoprolol Tartrate Milpharm is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious adverse events include severe bradycardia, heart block, hypotension, acute heart‑failure exacerbation, and bronchospasm in patients with underlying respiratory disease. Prompt medical attention is required if symptoms such as fainting, chest pain, or difficulty breathing occur.

Metoprolol Tartrate is contraindicated in patients with known hypersensitivity to the drug, those with severe bradycardia (heart rate < 45 bpm), second‑ or third‑degree atrioventricular block without a pacemaker, and individuals in cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or chronic obstructive pulmonary disease.